OPTISCAN IMAGING LIMITED - Announcements

Market Cap $179.5M Add to my watchlist

Healthcare Medical Devices

Optiscan Imaging Limited is an Australia-based company, which is engaged in the... Optiscan Imaging Limited is an Australia-based company, which is engaged in the development, manufacturing and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The Company’s technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. It provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is an intra-oral digital microscope that offers the power of single-cell oral imaging at your fingertips in the palm of your hand. Its ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

OIL	Optiscan Receives Ethical Clearance for Breast Cancer Study	PRICE SENSITIVE	15/07/24	401.21KB	Share
OIL	Optiscan 2024 Roadshow Presentation	PRICE SENSITIVE	01/07/24	2.44MB	Share
OIL	Optiscan Reveals InVue Imaging Device for Precision Surgery	PRICE SENSITIVE	04/06/24	172.87KB	Share
OIL	Optiscan Webinar Investor Presentation	PRICE SENSITIVE	16/05/24	1.95MB	Share
OIL	Optiscan Signs Know-How Agreement with Mayo Clinic	PRICE SENSITIVE	13/05/24	126.86KB	Share
OIL	OIL March 2024 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/04/24	277.05KB	Share
OIL	Optiscan appoints US Clinical & Regulatory Heads	PRICE SENSITIVE	02/04/24	114.29KB	Share
OIL	OIL Appendix 4D and 31 December 2023 Half-year report	PRICE SENSITIVE	23/02/24	1.6MB	Share
OIL	Optiscan receives $3 million CRC-P Industry Grant	PRICE SENSITIVE	13/02/24	114.39KB	Share
OIL	OIL December 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/24	324.61KB	Share
OIL	OIL Managing Director's Presentation & Chair's Address	PRICE SENSITIVE	23/11/23	2.88MB	Share
OIL	Response to ASX Price Query	PRICE SENSITIVE	14/11/23	223.26KB	Share
OIL	OIL September 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/23	323.62KB	Share
OIL	Optiscan Correlates with Histology in Breast Study	PRICE SENSITIVE	19/09/23	102.36KB	Share
OIL	OIL Appendix 4E and June 2023 Annual Report	PRICE SENSITIVE	31/08/23	1.69MB	Share
OIL	Optiscan Achieves Telepathology Milestone	PRICE SENSITIVE	15/08/23	106.06KB	Share
OIL	OIL June 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	28/07/23	326.14KB	Share
OIL	Entitlement Offer Results and Shortfall Announcement	PRICE SENSITIVE	12/07/23	91.36KB	Share
OIL	Optiscan Entitlement Issue Prospectus	PRICE SENSITIVE	30/05/23	636.42KB	Share
OIL	Optiscan Launches Entitlement Offer to Raise $16.7M	PRICE SENSITIVE	30/05/23	134.45KB	Share
OIL	Trading Halt	PRICE SENSITIVE	26/05/23	183.4KB	Share
OIL	OIL March 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	28/04/23	293.18KB	Share
OIL	Optiscan Platform Highly Accurate for Oral Cancer Diagnosis	PRICE SENSITIVE	14/03/23	108.11KB	Share
OIL	Optiscan Intends to pursue De Novo Pathway for InVivage	PRICE SENSITIVE	02/03/23	97.89KB	Share
OIL	OIL Appendix 4D and 31 December 2022 Half-year report	PRICE SENSITIVE	27/02/23	1.65MB	Share
OIL	Optiscan partners with Prolucid to develop AI Algorithms	PRICE SENSITIVE	30/01/23	99.21KB	Share
OIL	OIL December 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	27/01/23	402.35KB	Share
OIL	Optiscan Managing Director 2022 AGM Presentation	PRICE SENSITIVE	24/11/22	6.77MB	Share
OIL	OIL September 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/22	407.08KB	Share
OIL	Optiscan Imaging Acquires Intellectual Property	PRICE SENSITIVE	25/10/22	195.68KB	Share
OIL	Appendix 4E and 2022 Annual Report	PRICE SENSITIVE	31/08/22	1.08MB	Share
OIL	Optiscan Submits FDA 510(k) Application for InVivage Device	PRICE SENSITIVE	22/08/22	189.3KB	Share
OIL	OIL June 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/07/22	422.39KB	Share
OIL	Strategic Distribution Partnership - Additional Information	PRICE SENSITIVE	28/06/22	183.5KB	Share
OIL	Optiscan announces Strategic Distribution Partner for China	PRICE SENSITIVE	27/06/22	187.04KB	Share
OIL	OIL March 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/04/22	388.88KB	Share
OIL	Appendix 4D and 31 December 2021 Half-year report	PRICE SENSITIVE	24/02/22	606.54KB	Share
OIL	OIL December 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/22	398.39KB	Share
OIL	2021 AGM Chairman's Address and MD Presentation	PRICE SENSITIVE	20/01/22	3.32MB	Share
OIL	Change of Managing Director	PRICE SENSITIVE	13/12/21	202.2KB	Share
OIL	Completion of imaging for Melbourne Breast cancer trial	PRICE SENSITIVE	12/11/21	162.56KB	Share
OIL	OIL September 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	27/10/21	398.13KB	Share
OIL	Receipt of R&D Tax Incentive Rebate	PRICE SENSITIVE	25/10/21	142.02KB	Share
OIL	OIL FY21 Annual Results Presentation	PRICE SENSITIVE	30/08/21	1MB	Share
OIL	Appendix 4E and 2021 Annual Report	PRICE SENSITIVE	30/08/21	1.35MB	Share
OIL	OIL June 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/07/21	417.64KB	Share
OIL	Update on seeking United States FDA approval & market entry	PRICE SENSITIVE	01/06/21	160.88KB	Share
OIL	OIL March 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/04/21	395.38KB	Share
OIL	Appointment of New Non-executive Chair	PRICE SENSITIVE	19/04/21	208.78KB	Share
OIL	Appendix 4D and Financial Statements - 31 December 2020	PRICE SENSITIVE	25/02/21	1.13MB	Share
OIL	OIL breast cancer study to commence next stage - revised	PRICE SENSITIVE	08/02/21	199.92KB	Share
OIL	Optiscan breast cancer study to commence next stage	PRICE SENSITIVE	08/02/21	199.91KB	Share
OIL	OIL December 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/01/21	408.83KB	Share
OIL	Carl Zeiss Meditec AG Product Orders	PRICE SENSITIVE	13/01/21	195.7KB	Share
OIL	Appointment of Taiwan Distributor	PRICE SENSITIVE	16/12/20	198.48KB	Share
OIL	OIL 2020 AGM Presentation	PRICE SENSITIVE	26/11/20	1.28MB	Share
OIL	TGA Approval for CONVIVO and Sterile Sheath In Australia	PRICE SENSITIVE	10/11/20	173.49KB	Share
OIL	OIL September 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/10/20	408.9KB	Share
OIL	US FDA Regulatory Approval update	PRICE SENSITIVE	09/10/20	203.17KB	Share
OIL	OptiScan Capital Raising	PRICE SENSITIVE	25/09/20	227.65KB	Share
OIL	Optiscan Capital Raising	PRICE SENSITIVE	22/09/20	187.36KB	Share
OIL	Trading Halt	PRICE SENSITIVE	21/09/20	220.64KB	Share
OIL	Pause in Trading	PRICE SENSITIVE	21/09/20	116.4KB	Share
OIL	Response to ASX Price Query	PRICE SENSITIVE	08/09/20	292.87KB	Share
OIL	Appendix 4E and 2020 Annual Report	PRICE SENSITIVE	31/08/20	1.29MB	Share
OIL	New North American & Expanded Asia Pacific Distribution	PRICE SENSITIVE	28/08/20	176.02KB	Share
OIL	OIL June 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/07/20	413.75KB	Share
OIL	2 X China Tender Success for FIVE2 (ViewnVivo)	PRICE SENSITIVE	28/07/20	178.61KB	Share
OIL	Government grant to support Melbourne Dental School Trial	PRICE SENSITIVE	20/07/20	227.17KB	Share
OIL	Achievement of Final Milestone in Carl Zeiss Agreement	PRICE SENSITIVE	04/05/20	200.1KB	Share
OIL	OIL March 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/04/20	403.99KB	Share
OIL	Response to ASX Price Query	PRICE SENSITIVE	07/04/20	794.58KB	Share
OIL	Pause in Trading	PRICE SENSITIVE	07/04/20	115.4KB	Share
OIL	Corporate Update	PRICE SENSITIVE	20/03/20	218.19KB	Share
OIL	Appendix 4D and Financial Statements - 31 December 2019	PRICE SENSITIVE	28/02/20	819.49KB	Share
OIL	Corporate Update - January 2020	PRICE SENSITIVE	31/01/20	200.44KB	Share
OIL	Appointment of Second China Distributor	PRICE SENSITIVE	05/12/19	200.25KB	Share
OIL	2019 AGM Presentation	PRICE SENSITIVE	28/11/19	2.03MB	Share
OIL	Optiscan Market Update	PRICE SENSITIVE	25/11/19	204.25KB	Share
OIL	OIL initiates FDA feedback for Oral Cancer 510(k) submission	PRICE SENSITIVE	04/11/19	205.09KB	Share
OIL	Appointment of new China Distributor	PRICE SENSITIVE	16/10/19	206.44KB	Share
OIL	Leading Aus & US Hospital Collaboration to trial OIL device	PRICE SENSITIVE	23/09/19	209.84KB	Share
OIL	Appendix 4E and 2019 Annual Report	PRICE SENSITIVE	30/08/19	1.3MB	Share
OIL	Optiscan System Approved for Prestigious Cancer Centre Trial	PRICE SENSITIVE	21/08/19	212.1KB	Share
OIL	Investor Presentation - June 2019	PRICE SENSITIVE	14/06/19	1.26MB	Share
OIL	Optiscan Secures Strong Support in $1.70 M Capital Raising	PRICE SENSITIVE	14/06/19	201.9KB	Share
OIL	Trading Halt	PRICE SENSITIVE	12/06/19	382.3KB	Share
OIL	OptiScan March 2019 Presentation	PRICE SENSITIVE	14/03/19	2.03MB	Share
OIL	Appendix 4D and Financial Statements - 31 Dec 2018	PRICE SENSITIVE	28/02/19	905.77KB	Share
OIL	Collaboration Agreement with Summit Biomedical Imaging LLC	PRICE SENSITIVE	26/02/19	177.1KB	Share
OIL	OptiScan technology used in research at major cancer centre	PRICE SENSITIVE	26/02/19	177.57KB	Share
OIL	Receipt of R&D Tax Incentive Rebate	PRICE SENSITIVE	08/11/18	574KB	Share
OIL	Reinstatement to Official Quotation	PRICE SENSITIVE	07/11/18	213.2KB	Share
OIL	ZEISS achieves another milestone on regulatory pathway	PRICE SENSITIVE	07/11/18	575.3KB	Share
OIL	Suspension from Official Quotation	PRICE SENSITIVE	02/11/18	676.54KB	Share
OIL	Trading Halt	PRICE SENSITIVE	31/10/18	212.15KB	Share
OIL	Clinical Trial - Assessment of Breast Cancer Margin	PRICE SENSITIVE	15/10/18	133.41KB	Share
OIL	Appendix 4E and 2018 Annual Report	PRICE SENSITIVE	31/08/18	1.08MB	Share
OIL	Receipt of R&D Tax Incentive Rebate	PRICE SENSITIVE	26/06/18	74.31KB	Share
OIL	Market Update	PRICE SENSITIVE	13/06/18	199.87KB	Share

OIL Optiscan Receives Ethical Clearance for Breast Cancer Study
15/07/24	PRICE SENSITIVE	401.21KB	Share
OIL Optiscan 2024 Roadshow Presentation
01/07/24	PRICE SENSITIVE	2.44MB	Share
OIL Optiscan Reveals InVue Imaging Device for Precision Surgery
04/06/24	PRICE SENSITIVE	172.87KB	Share
OIL Optiscan Webinar Investor Presentation
16/05/24	PRICE SENSITIVE	1.95MB	Share
OIL Optiscan Signs Know-How Agreement with Mayo Clinic
13/05/24	PRICE SENSITIVE	126.86KB	Share
OIL OIL March 2024 Quarterly Report and Appendix 4C
30/04/24	PRICE SENSITIVE	277.05KB	Share
OIL Optiscan appoints US Clinical & Regulatory Heads
02/04/24	PRICE SENSITIVE	114.29KB	Share
OIL OIL Appendix 4D and 31 December 2023 Half-year report
23/02/24	PRICE SENSITIVE	1.6MB	Share
OIL Optiscan receives $3 million CRC-P Industry Grant
13/02/24	PRICE SENSITIVE	114.39KB	Share
OIL OIL December 2023 Quarterly Report and Appendix 4C
31/01/24	PRICE SENSITIVE	324.61KB	Share
OIL OIL Managing Director's Presentation & Chair's Address
23/11/23	PRICE SENSITIVE	2.88MB	Share
OIL Response to ASX Price Query
14/11/23	PRICE SENSITIVE	223.26KB	Share
OIL OIL September 2023 Quarterly Report and Appendix 4C
31/10/23	PRICE SENSITIVE	323.62KB	Share
OIL Optiscan Correlates with Histology in Breast Study
19/09/23	PRICE SENSITIVE	102.36KB	Share
OIL OIL Appendix 4E and June 2023 Annual Report
31/08/23	PRICE SENSITIVE	1.69MB	Share
OIL Optiscan Achieves Telepathology Milestone
15/08/23	PRICE SENSITIVE	106.06KB	Share
OIL OIL June 2023 Quarterly Report and Appendix 4C
28/07/23	PRICE SENSITIVE	326.14KB	Share
OIL Entitlement Offer Results and Shortfall Announcement
12/07/23	PRICE SENSITIVE	91.36KB	Share
OIL Optiscan Entitlement Issue Prospectus
30/05/23	PRICE SENSITIVE	636.42KB	Share
OIL Optiscan Launches Entitlement Offer to Raise $16.7M
30/05/23	PRICE SENSITIVE	134.45KB	Share
OIL Trading Halt
26/05/23	PRICE SENSITIVE	183.4KB	Share
OIL OIL March 2023 Quarterly Report and Appendix 4C
28/04/23	PRICE SENSITIVE	293.18KB	Share
OIL Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
14/03/23	PRICE SENSITIVE	108.11KB	Share
OIL Optiscan Intends to pursue De Novo Pathway for InVivage
02/03/23	PRICE SENSITIVE	97.89KB	Share
OIL OIL Appendix 4D and 31 December 2022 Half-year report
27/02/23	PRICE SENSITIVE	1.65MB	Share
OIL Optiscan partners with Prolucid to develop AI Algorithms
30/01/23	PRICE SENSITIVE	99.21KB	Share
OIL OIL December 2022 Quarterly Report and Appendix 4C
27/01/23	PRICE SENSITIVE	402.35KB	Share
OIL Optiscan Managing Director 2022 AGM Presentation
24/11/22	PRICE SENSITIVE	6.77MB	Share
OIL OIL September 2022 Quarterly Report and Appendix 4C
31/10/22	PRICE SENSITIVE	407.08KB	Share
OIL Optiscan Imaging Acquires Intellectual Property
25/10/22	PRICE SENSITIVE	195.68KB	Share
OIL Appendix 4E and 2022 Annual Report
31/08/22	PRICE SENSITIVE	1.08MB	Share
OIL Optiscan Submits FDA 510(k) Application for InVivage Device
22/08/22	PRICE SENSITIVE	189.3KB	Share
OIL OIL June 2022 Quarterly Report and Appendix 4C
29/07/22	PRICE SENSITIVE	422.39KB	Share
OIL Strategic Distribution Partnership - Additional Information
28/06/22	PRICE SENSITIVE	183.5KB	Share
OIL Optiscan announces Strategic Distribution Partner for China
27/06/22	PRICE SENSITIVE	187.04KB	Share
OIL OIL March 2022 Quarterly Report and Appendix 4C
29/04/22	PRICE SENSITIVE	388.88KB	Share
OIL Appendix 4D and 31 December 2021 Half-year report
24/02/22	PRICE SENSITIVE	606.54KB	Share
OIL OIL December 2021 Quarterly Report and Appendix 4C
31/01/22	PRICE SENSITIVE	398.39KB	Share
OIL 2021 AGM Chairman's Address and MD Presentation
20/01/22	PRICE SENSITIVE	3.32MB	Share
OIL Change of Managing Director
13/12/21	PRICE SENSITIVE	202.2KB	Share
OIL Completion of imaging for Melbourne Breast cancer trial
12/11/21	PRICE SENSITIVE	162.56KB	Share
OIL OIL September 2021 Quarterly Report and Appendix 4C
27/10/21	PRICE SENSITIVE	398.13KB	Share
OIL Receipt of R&D Tax Incentive Rebate
25/10/21	PRICE SENSITIVE	142.02KB	Share
OIL OIL FY21 Annual Results Presentation
30/08/21	PRICE SENSITIVE	1MB	Share
OIL Appendix 4E and 2021 Annual Report
30/08/21	PRICE SENSITIVE	1.35MB	Share
OIL OIL June 2021 Quarterly Report and Appendix 4C
30/07/21	PRICE SENSITIVE	417.64KB	Share
OIL Update on seeking United States FDA approval & market entry
01/06/21	PRICE SENSITIVE	160.88KB	Share
OIL OIL March 2021 Quarterly Report and Appendix 4C
29/04/21	PRICE SENSITIVE	395.38KB	Share
OIL Appointment of New Non-executive Chair
19/04/21	PRICE SENSITIVE	208.78KB	Share
OIL Appendix 4D and Financial Statements - 31 December 2020
25/02/21	PRICE SENSITIVE	1.13MB	Share
OIL OIL breast cancer study to commence next stage - revised
08/02/21	PRICE SENSITIVE	199.92KB	Share
OIL Optiscan breast cancer study to commence next stage
08/02/21	PRICE SENSITIVE	199.91KB	Share
OIL OIL December 2020 Quarterly Report and Appendix 4C
29/01/21	PRICE SENSITIVE	408.83KB	Share
OIL Carl Zeiss Meditec AG Product Orders
13/01/21	PRICE SENSITIVE	195.7KB	Share
OIL Appointment of Taiwan Distributor
16/12/20	PRICE SENSITIVE	198.48KB	Share
OIL OIL 2020 AGM Presentation
26/11/20	PRICE SENSITIVE	1.28MB	Share
OIL TGA Approval for CONVIVO and Sterile Sheath In Australia
10/11/20	PRICE SENSITIVE	173.49KB	Share
OIL OIL September 2020 Quarterly Report and Appendix 4C
30/10/20	PRICE SENSITIVE	408.9KB	Share
OIL US FDA Regulatory Approval update
09/10/20	PRICE SENSITIVE	203.17KB	Share
OIL OptiScan Capital Raising
25/09/20	PRICE SENSITIVE	227.65KB	Share
OIL Optiscan Capital Raising
22/09/20	PRICE SENSITIVE	187.36KB	Share
OIL Trading Halt
21/09/20	PRICE SENSITIVE	220.64KB	Share
OIL Pause in Trading
21/09/20	PRICE SENSITIVE	116.4KB	Share
OIL Response to ASX Price Query
08/09/20	PRICE SENSITIVE	292.87KB	Share
OIL Appendix 4E and 2020 Annual Report
31/08/20	PRICE SENSITIVE	1.29MB	Share
OIL New North American & Expanded Asia Pacific Distribution
28/08/20	PRICE SENSITIVE	176.02KB	Share
OIL OIL June 2020 Quarterly Report and Appendix 4C
31/07/20	PRICE SENSITIVE	413.75KB	Share
OIL 2 X China Tender Success for FIVE2 (ViewnVivo)
28/07/20	PRICE SENSITIVE	178.61KB	Share
OIL Government grant to support Melbourne Dental School Trial
20/07/20	PRICE SENSITIVE	227.17KB	Share
OIL Achievement of Final Milestone in Carl Zeiss Agreement
04/05/20	PRICE SENSITIVE	200.1KB	Share
OIL OIL March 2020 Quarterly Report and Appendix 4C
30/04/20	PRICE SENSITIVE	403.99KB	Share
OIL Response to ASX Price Query
07/04/20	PRICE SENSITIVE	794.58KB	Share
OIL Pause in Trading
07/04/20	PRICE SENSITIVE	115.4KB	Share
OIL Corporate Update
20/03/20	PRICE SENSITIVE	218.19KB	Share
OIL Appendix 4D and Financial Statements - 31 December 2019
28/02/20	PRICE SENSITIVE	819.49KB	Share
OIL Corporate Update - January 2020
31/01/20	PRICE SENSITIVE	200.44KB	Share
OIL Appointment of Second China Distributor
05/12/19	PRICE SENSITIVE	200.25KB	Share
OIL 2019 AGM Presentation
28/11/19	PRICE SENSITIVE	2.03MB	Share
OIL Optiscan Market Update
25/11/19	PRICE SENSITIVE	204.25KB	Share
OIL OIL initiates FDA feedback for Oral Cancer 510(k) submission
04/11/19	PRICE SENSITIVE	205.09KB	Share
OIL Appointment of new China Distributor
16/10/19	PRICE SENSITIVE	206.44KB	Share
OIL Leading Aus & US Hospital Collaboration to trial OIL device
23/09/19	PRICE SENSITIVE	209.84KB	Share
OIL Appendix 4E and 2019 Annual Report
30/08/19	PRICE SENSITIVE	1.3MB	Share
OIL Optiscan System Approved for Prestigious Cancer Centre Trial
21/08/19	PRICE SENSITIVE	212.1KB	Share
OIL Investor Presentation - June 2019
14/06/19	PRICE SENSITIVE	1.26MB	Share
OIL Optiscan Secures Strong Support in $1.70 M Capital Raising
14/06/19	PRICE SENSITIVE	201.9KB	Share
OIL Trading Halt
12/06/19	PRICE SENSITIVE	382.3KB	Share
OIL OptiScan March 2019 Presentation
14/03/19	PRICE SENSITIVE	2.03MB	Share
OIL Appendix 4D and Financial Statements - 31 Dec 2018
28/02/19	PRICE SENSITIVE	905.77KB	Share
OIL Collaboration Agreement with Summit Biomedical Imaging LLC
26/02/19	PRICE SENSITIVE	177.1KB	Share
OIL OptiScan technology used in research at major cancer centre
26/02/19	PRICE SENSITIVE	177.57KB	Share
OIL Receipt of R&D Tax Incentive Rebate
08/11/18	PRICE SENSITIVE	574KB	Share
OIL Reinstatement to Official Quotation
07/11/18	PRICE SENSITIVE	213.2KB	Share
OIL ZEISS achieves another milestone on regulatory pathway
07/11/18	PRICE SENSITIVE	575.3KB	Share
OIL Suspension from Official Quotation
02/11/18	PRICE SENSITIVE	676.54KB	Share
OIL Trading Halt
31/10/18	PRICE SENSITIVE	212.15KB	Share
OIL Clinical Trial - Assessment of Breast Cancer Margin
15/10/18	PRICE SENSITIVE	133.41KB	Share
OIL Appendix 4E and 2018 Annual Report
31/08/18	PRICE SENSITIVE	1.08MB	Share
OIL Receipt of R&D Tax Incentive Rebate
26/06/18	PRICE SENSITIVE	74.31KB	Share
OIL Market Update
13/06/18	PRICE SENSITIVE	199.87KB	Share

REFRESH

(20min delay)
Last 21.5¢		Change 0.015(7.50%)		Mkt cap ! $179.5M

Open	High	Low	Value	Volume
20.0¢	22.0¢	20.0¢	$67.20K	322.2K

Buyers (Bids)

No.	Vol.	Price($)
2	45149	21.5¢

Sellers (Offers)

Price($)	Vol.	No.
22.5¢	26834	2

View Market Depth

No.	Vol.	Price($)
2	45149	0.215
1	2142	0.210
1	3000	0.205
2	52525	0.200
6	97744	0.195

Price($)	Vol.	No.
0.225	26834	2
0.230	96207	6
0.235	55000	1
0.240	50000	1
0.245	109500	2

Last trade - 16.10pm 26/07/2024 (20 minute delay)


Last 22.0¢		Change 0.015 ( 0.50 %)
Open	High	Low	Volume
20.0¢	22.0¢	20.0¢	70083
Last updated 15.40pm 26/07/2024 ?

OIL (ASX) Chart

OPTISCAN IMAGING LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available